Volume 20, Number 8—August 2014
Dispatch
New Introductions of Enterovirus 71 Subgenogroup C4 Strains, France, 2012
Table
Patient no., hospital location† | Date admitted | Age at diagnosis | Clinical signs | Laboratory values for CSF |
Enterovirus RT-PCR results, Ct‡ |
Duration, d |
|||||
---|---|---|---|---|---|---|---|---|---|---|---|
Leukocytes/ mm3 | Protein, g/L | CSF | NP | Hospital stay | Antimicrobial drug use | ||||||
1, Nantes | Feb 12 | 6 d | Fever syndrome | <2 | 0.54 | Pos, 36.0 | Pos, 36.2 | 4.0 | 4.0 | ||
2, Versailles | Mar 12 | 17 d | Fever syndrome | 53 | 0.52 | Pos, 31.7 | NA | 2.5 | 2.5 | ||
3, Grasse | Jun 12 | 4.5 y | Fever syndrome, meningitis | 83§ | 0.92§ | Neg | Pos, 27.4 | 1.0 | 0 | ||
4, Rennes | Oct 12 | 21 d | Fever syndrome, rhinitis | 234 | 0.77 | Pos, 30.0 | NA | 6.0 | 3.0 |
*For all 4 children, molecular testing results were negative for the detection of herpes simplex virus types 1 and 2 and varicella-zoster virus in CSF. In addition, for patients 1 and 4, molecular testing results were also negative for the detection of human herpesvirus type 6, cytomegalovirus, and Epstein-Barr virus. Results were also negative for CSF bacterial cultures. CSF, cerebrospinal fluid sample; Ct, cycle threshold; NA, not available; Neg, negative NP, nasopharyngeal sample; Pos, positive; RT-PCR, reverse transcription PCR.
†Nantes (47°13′N; 1°33′W; Brittany); Versailles (48°48′N; 2°08′E; Ile de France); Grasse (43°40′N; 6°55′E; Provence-Alpes-Côte d’Azur); Rennes (48°06′N; 1°40′W; Brittany).
‡The upper Ct for positivity for each of the RT-PCR assays used was 45.0. An in-house enterovirus real-time RT-PCR was used to test samples from patient 1. A commercial RT-PCR assay produced by Cepheid and commercialized by Orgentec (GP-EV-040, Orgentec, Trappes, France) was used to test samples from patients 2 and 3. Another commercial RT-PCR assay, Dia-ENT-050 (Diagenode, Seraing, Belgium) was used to test samples from patient 4.
§CSF sample was hemorrhagic (10,300 erythrocytes/mm3).